Targeting RNA to treat neuromuscular disease.

Targeting RNA to treat neuromuscular disease.

The development of effective therapies for neuromuscular disorders such as Duchenne muscular dystrophy (DMD) is hampered by considerable challenges: skeletal muscle is the most abundant tissue in the body, and many neuromuscular disorders are multisystemic conditions. However, despite these barriers...

Полное описание

Библиографические подробности
Главные авторы:	Muntoni, F, Wood, M
Формат:	Journal article
Язык:	English
Опубликовано:	2011

Схожие документы

RNA-targeted splice-correction therapy for neuromuscular disease.
по: Wood, M, и др.
Опубликовано: (2010)

Syncoilin upregulation in muscle of patients with neuromuscular disease.
по: Brown, S, и др.
Опубликовано: (2005)

Splicing therapy for neuromuscular disease.
по: Douglas, A, и др.
Опубликовано: (2013)

Syncoilin expression in neuromuscular disorders
по: Torelli, S, и др.
Опубликовано: (2001)

Syncoilin expression in neuromuscular disorders.
по: Howman, E, и др.
Опубликовано: (2001)

Establishment and application of clinical biobanks in treating neuromuscular diseases
по: Ya-wen ZHAO, и др.
Опубликовано: (2016-10-01)

Emerging oligonucleotide therapeutics for rare neuromuscular diseases
по: Aoki, Y, и др.
Опубликовано: (2021)

Editorial: Genome and transcriptome editing to understand and treat neuromuscular diseases
по: Rika Maruyama, и др.
Опубликовано: (2023-03-01)

RNA interference: from model organisms towards therapy for neural and neuromuscular disorders.
по: Buckingham, S, и др.
Опубликовано: (2004)

Clinical advances of RNA therapeutics for treatment of neurological and neuromuscular diseases
по: Anja Holm, и др.
Опубликовано: (2022-12-01)

Systemic delivery of MicroRNA using recombinant adeno-associated virus serotype 9 to treat neuromuscular diseases in rodents
по: Pourshafie, N, и др.
Опубликовано: (2018)

Emergency neuromuscular admissions are avoidable: a regional audit of unplanned hospital admissions of neuromuscular patients 2009-2011: final results and recommendations.
по: Jaffer, F, и др.
Опубликовано: (2013)

RNA Targeting in Inherited Neuromuscular Disorders: Novel Therapeutic Strategies to Counteract Mis-Splicing
по: Veronica Verdile, и др.
Опубликовано: (2021-10-01)

Subcutaneous immunoglobulin in treating inflammatory neuromuscular disorders
по: Min-Suk Yoon, и др.
Опубликовано: (2015-07-01)

Multiple roles of integrin-α3 at the neuromuscular junction.
по: Ross, J, и др.
Опубликовано: (2017)

Treating neuromuscular diseases: unveiling gene therapy breakthroughs and pioneering future applications
по: Yu-Fu Wu, и др.
Опубликовано: (2025-02-01)

Abdominal compartment syndrome successfully treated with neuromuscular blockade
по: Kris T Chiles, и др.
Опубликовано: (2011-01-01)

Diseases of the neuromuscular junction.
по: McConville, J, и др.
Опубликовано: (2002)

Diagnosing Neuromuscular Diseases
по: Alberto L. Dubrovsky
Опубликовано: (2018-08-01)

Neuromuscular Diseases and Bone
по: Giovanni Iolascon, и др.
Опубликовано: (2019-11-01)

Neuromuscular diseases and anesthesia
по: Antonijević Vesna, и др.
Опубликовано: (2018-01-01)

Role of RNA Binding Proteins with prion-like domains in muscle and neuromuscular diseases
по: Gina Picchiarelli, и др.
Опубликовано: (2020-03-01)

Protein defects in neuromuscular diseases
по: Vainzof M., и др.
Опубликовано: (2003-01-01)

Downregulation of myostatin pathway in neuromuscular diseases may explain challenges of anti-myostatin therapeutic approaches
по: Mariot, V, и др.
Опубликовано: (2017)

Neuromuscular Blockade for Cardiac Arrest Patients Treated With Targeted Temperature Management: A Systematic Review and Meta-Analysis
по: Tong Lin, и др.
Опубликовано: (2022-05-01)

Critical Illness Neuromuscular Disease
по: J Gordon Millichap
Опубликовано: (1995-02-01)

Neuromuscular disease: 2023 update
по: Marta Margeta
Опубликовано: (2023-02-01)

Modeling neuromuscular diseases in zebrafish
по: Jaskaran Singh, и др.
Опубликовано: (2022-12-01)

Neuromuscular diseases: revisiting the "overtraining"
по: Marco Orsini, и др.
Опубликовано: (2014-04-01)

Editorial: Imaging of Neuromuscular Diseases
по: Jordi Diaz-Manera, и др.
Опубликовано: (2021-12-01)

Management of patients with neuromuscular disease /
по: Bach, John R., 1950-
Опубликовано: (c200)

Development of a high-throughput tailored imaging method in zebrafish to understand and treat neuromuscular diseases
по: Léa Lescouzères, и др.
Опубликовано: (2022-09-01)

Doenças neuromusculares Neuromuscular disorders
по: Umbertina C. Reed
Опубликовано: (2002-08-01)

The Impact of Mitochondrial Deficiencies in Neuromuscular Diseases
по: Judith Cantó-Santos, и др.
Опубликовано: (2020-10-01)

Predictors of overload in parents of children with neuromuscular diseases
по: A. A. Rodríguez, и др.
Опубликовано: (2024-02-01)

Molecular targets for autoimmune and genetic disorders of neuromuscular transmission.
по: Vincent, A, и др.
Опубликовано: (2000)

Neuromuscular disease. DOK7 gene therapy benefits mouse models of diseases characterized by defects in the neuromuscular junction.
по: Arimura, S, и др.
Опубликовано: (2014)

RNA and glia at the Drosophila neuromuscular junction: importance for synaptic plasticity
по: Gala, DS
Опубликовано: (2023)

Impaired neuromuscular transmission and response to acetylcholinesterase inhibitors in centronuclear myopathies.
по: Robb, SA, и др.
Опубликовано: (2011)

Downregulation of myostatin pathway in neuromuscular diseases may explain challenges of anti-myostatin therapeutic approaches
по: Virginie Mariot, и др.
Опубликовано: (2017-11-01)